Emergence of Haemophilus influenzae with low susceptibility to quinolones isolated from pediatric patients in Japan. Issue 7 (July 2021)
- Record Type:
- Journal Article
- Title:
- Emergence of Haemophilus influenzae with low susceptibility to quinolones isolated from pediatric patients in Japan. Issue 7 (July 2021)
- Main Title:
- Emergence of Haemophilus influenzae with low susceptibility to quinolones isolated from pediatric patients in Japan
- Authors:
- Takeuchi, Noriko
Ohkusu, Misako
Hoshino, Tadashi
Yamamoto, Shota
Segawa, Shunsuke
Murata, Shota
Ishiwada, Naruhiko - Abstract:
- Abstract: Introduction: In 2010, oral fluoroquinolone tosufloxacin (TFX) granules were released as the first oral respiratory quinolone for children in Japan. Methods: To investigate the recent trend of H. influenzae strains with low susceptibility to quinolones in children, we analyzed the gene sequences of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC, and parE of 23 clinical isolates from 15 patients aged <15 years with an MIC of ≥0.5 μg/mL for TFX from 2010 to 2018. Results: Amino acid substitutions were observed in both GyrA and ParC in 13 strains (81%, 13/16), except two strains with a TFX MIC of 0.5 μg/mL with amino acid substitution in only GyrA and one strain with a TFX MIC of 1 μg/mL with no amino acid substitution. Four ST422 strains were observed in 2018, the detection age range was wide (0–7 years), and the residential city was varied. A total of 3/15 patients had a clear history of TFX treatment. Conclusions: Even for the strain with an MIC of 0.5 μg/mL for TFX, it is highly possible that it harbors a mutation in gyrA, which is the first step toward quinolone resistance, and it may also harbor mutations in both gyrA and parC . Furthermore, several specific sequence type quinolone-resistant H. influenzae strains, particularly ST422, may be widespread among children in Japan. It is necessary to investigate changes in resistance both at the MIC and gene levels. The continuous monitoring of strains and the use of antimicrobial drugs inAbstract: Introduction: In 2010, oral fluoroquinolone tosufloxacin (TFX) granules were released as the first oral respiratory quinolone for children in Japan. Methods: To investigate the recent trend of H. influenzae strains with low susceptibility to quinolones in children, we analyzed the gene sequences of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC, and parE of 23 clinical isolates from 15 patients aged <15 years with an MIC of ≥0.5 μg/mL for TFX from 2010 to 2018. Results: Amino acid substitutions were observed in both GyrA and ParC in 13 strains (81%, 13/16), except two strains with a TFX MIC of 0.5 μg/mL with amino acid substitution in only GyrA and one strain with a TFX MIC of 1 μg/mL with no amino acid substitution. Four ST422 strains were observed in 2018, the detection age range was wide (0–7 years), and the residential city was varied. A total of 3/15 patients had a clear history of TFX treatment. Conclusions: Even for the strain with an MIC of 0.5 μg/mL for TFX, it is highly possible that it harbors a mutation in gyrA, which is the first step toward quinolone resistance, and it may also harbor mutations in both gyrA and parC . Furthermore, several specific sequence type quinolone-resistant H. influenzae strains, particularly ST422, may be widespread among children in Japan. It is necessary to investigate changes in resistance both at the MIC and gene levels. The continuous monitoring of strains and the use of antimicrobial drugs in treatment should be carefully observed. … (more)
- Is Part Of:
- Journal of infection and chemotherapy. Volume 27:Issue 7(2021)
- Journal:
- Journal of infection and chemotherapy
- Issue:
- Volume 27:Issue 7(2021)
- Issue Display:
- Volume 27, Issue 7 (2021)
- Year:
- 2021
- Volume:
- 27
- Issue:
- 7
- Issue Sort Value:
- 2021-0027-0007-0000
- Page Start:
- 1020
- Page End:
- 1026
- Publication Date:
- 2021-07
- Subjects:
- Haemophilus influenzae -- Quinolone-resistant -- Fluoroquinolone
AMC amoxicillin-clavulanic acid -- AMP ampicillin -- BLNAI β-lactamase-nonproducing ampicillin-intermediately resistant Haemophilus influenzae -- BLNAR β-lactamase nonproducing ampicillin-resistant Haemophilus influenzae -- BLNAS β-lactamase-nonproducing ampicillin-sensitive Haemophilus influenzae -- BLPACR β-lactamase-producing amoxicillin-clavulanic acid-resistant Haemophilus influenzae -- BLPAR β-lactamase-producing ampicillin-resistant Haemophilus influenzae -- CLSI Clinical and Laboratory Standards Institute -- LVX levofloxacin -- MALDI-TOF MS matrix-associated laser desorption/ionization time-of-flight mass spectrometry -- MIC minimum inhibitory concentration -- MLST multilocus sequence typing -- NTHi nontypeable Haemophilus influenzae -- QRDR quinolone resistance-determining region -- ST sequence type -- TFX tosufloxacin
Chemotherapy -- Periodicals
Infection -- Periodicals
Communicable diseases -- Chemotherapy -- Periodicals
615.5805 - Journal URLs:
- http://www.sciencedirect.com/science/journal/1341321X ↗
http://link.springer-ny.com/link/service/journals/10156/index.htm ↗
http://www.springerlink.com/content/1341-321x ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1016/j.jiac.2021.02.022 ↗
- Languages:
- English
- ISSNs:
- 1341-321X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.691000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18238.xml